Literature DB >> 27126760

Port protectors in clinical practice: an audit.

Corinne Cameron-Watson1.   

Abstract

This article discusses the effect on compliance and incidence of vascular access device (VAD)-related bacteraemia following the introduction of a passive disinfection device (Curos®) for 6 months in four areas at one hospital trust. The hospital's infection prevention and control team replaced the 'active' disinfection using a disinfection wipe with 'scrub the hub'. Disinfection wipes used for needle-free devices were removed from all four trial areas and Curos was incorporated into the aseptic non-touch technique (ANTT(®)) protocols for the trial wards. Staff training was provided before and during the study, and audits of staff compliance with Curos placement were undertaken monthly. A benchmarking audit of 'scrub the hub' techniques was conducted 1 month before audit began. The results of the audit showed VAD-related bacteraemia rates reduced by 69% from 26 cases (confirmed through review of blood culture laboratory data and source identified by consultant microbiologists) before the study, to 8 when staff compliance with Curos placement onto VADs was 80% or more.

Entities:  

Keywords:  Catheter-related infections; Compliance; Disinfection; Infection control

Mesh:

Year:  2016        PMID: 27126760     DOI: 10.12968/bjon.2016.25.8.S25

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  2 in total

Review 1.  Curos™ Disinfection Caps for the Prevention of Infection When Using Needleless Connectors: A NICE Medical Technologies Guidance.

Authors:  Susan O'Connell; Megan Dale; Helen Morgan; Kimberley Carter; Grace Carolan-Rees
Journal:  Appl Health Econ Health Policy       Date:  2021-03       Impact factor: 2.561

2.  An in vitro comparison of standard cleaning to a continuous passive disinfection cap for the decontamination of needle-free connectors.

Authors:  Anna L Casey; Tarja J Karpanen; Peter Nightingale; Tom S J Elliott
Journal:  Antimicrob Resist Infect Control       Date:  2018-04-05       Impact factor: 4.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.